Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited) (Parentheticals)

v3.23.1
Consolidated Balance Sheets (Unaudited) (Parentheticals)
Mar. 31, 2023
USD ($)
shares
Mar. 31, 2023
₪ / shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
₪ / shares
Statement of Financial Position [Abstract]        
Accounts receivable, net of allowance for credit losses (in Dollars) | $ $ 800   $ 900  
Ordinary shares, par value (in New Shekels per share) | ₪ / shares   ₪ 0.01   ₪ 0.01
Ordinary shares, authorized 180,000   180,000  
Ordinary shares, issued 68,103   67,086  
Ordinary shares, outstanding 68,103   67,086